CliffBio
small molecule

YUTIQ

FLUOCINOLONE ACETONIDE

Loss of exclusivityJanuary 2028latest FDA-listed patent expiry
CompanyAlimera Sciences →See this company's full patent-cliff portfolio

Drug detail

Brand nameYUTIQ
Active ingredientFLUOCINOLONE ACETONIDE
Strength0.18MG
Dosage formIMPLANT
RouteINTRAVITREAL
ModalitySmall molecule
FDA approvalOctober 2018
Marketing statusDISCN

Listed patents

PatentExpiresType
7998108January 2028product
8871241August 2027product

More from Alimera Sciences

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.